首页> 美国卫生研究院文献>Clinical and Experimental Immunology >Modulation of the immune response by immunoglobulin for intravenous use. I. Inhibition of pokeweed mitogen-induced B cell differentiation.
【2h】

Modulation of the immune response by immunoglobulin for intravenous use. I. Inhibition of pokeweed mitogen-induced B cell differentiation.

机译:免疫球蛋白对免疫反应的调节供静脉内使用。 I.商陆有丝分裂原诱导的B细胞分化的抑制作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The effect of a commercially available intravenous gammaglobulin preparation (IgSRK; Sandoglobulin) on the antigen-non-specific activation of the immune system was examined using pokeweed mitogen (PWM)-induced B cell differentiation. In cultures of peripheral blood mononuclear cells from 16 normal donors, IgSRK (300 micrograms/ml) inhibited PWM-induced generation of plaque-forming cells by 76% (P less than 0.001), whereas human serum albumin (300 micrograms/ml) induced no significant inhibition (5%; P not significant). The IgSRK-mediated suppression was demonstrable in both serum-containing (76%) and serum-free (63%) media, and monomeric IgSRK suppressed as effectively as did heat-aggregated IgSRK. F(ab')2 fragments exhibited no inhibitory capacity (mean inhibition -11%; P not significant) suggesting that the Fc portion of IgSRK may be required for suppression. In addition, IgSRK had to be added to the cultures at their initiation to effect full inhibition. These studies suggest a potential beneficial pharmacological role for IgSRK in the treatment of disorders characterized by pathogenic autoantibodies, but also warn of a potential deleterious effect of inhibiting the host's humoral response to an infectious challenge.
机译:使用商陆有丝分裂原(PWM)诱导的B细胞分化,检查了市售静脉内球蛋白(IgSRK; Sandoglobulin)制剂对免疫系统的抗原非特异性激活的影响。在来自16位正常供体的外周血单核细胞培养物中,IgSRK(300微克/毫升)抑制了PWM诱导的斑块形成细胞生成76%(P小于0.001),而人血清白蛋白(300微克/毫升)诱导了无明显抑制作用(5%; P不明显)。在含血清(76%)和无血清(63%)的培养基中均可证明IgSRK介导的抑制作用,单体IgSRK的抑制作用与热聚集的IgSRK一样有效。 F(ab')2片段未显示抑制能力(平均抑制-11%; P不显着),表明可能需要IgSRK的Fc部分进行抑制。另外,必须在培养开始时将IgSRK添加到培养物中以实现完全抑制。这些研究表明,IgSRK在治疗以致病性自身抗体为特征的疾病中可能具有潜在的有益药理作用,但也警告了抑制宿主对感染性体液反应的潜在有害作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号